Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers

Journal of Clinical Pharmacology

Volumn 36, Issue 5, 1996, Pages 469-476

  Min, David I ^a   Ku, Yi Min ^a   Geraets, Douglas R ^a   Lee, Hon Chi ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYQUINIDINE; QUINIDINE SULFATE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; FOOD DRUG INTERACTION; FRUIT JUICE; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029885322     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb05034.x     Document Type: Article

References (35)

1. Guengerich FP, Brian WR, Iwasaki M, Sari MA, Bäärnhielm C, Berntsson P: Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P450 IIIA4. J Med Chem 1991;34:1838-1844.
2. Slaughter RL, Edwards DJ: Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995;29:619-624.
3. Guengerich FP, Müllerenoch D, Blair IA: Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 1986;39: 287-295.
4. Kronbach T: Cyclosporine metabolism in human liver: identification of cytochrome P450III gene family as the major cyclosporine metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988;43:630-635.
5. Watkins PB, Schults EG, Molowa DT, Guxelian PS: Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 1987;80:1029-1036.
6. Bailey DG, Spence JD, Munoz C, Arnold JM: Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-269.
7. Bailey DG, Arnold JM, Munoz C, Spence JD: Grapefruit juice/ felodipine interaction: mechanism, predictability, and effect of naringin. Clin Pharmacol Ther 1993;53:637-642.
8. Edgar B, Bailey D, Bergstrand R, Johnsson G, Regårdh CG: Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics on felodipine and its potential clinical relevance. Eur J Clin Pharmacoi 1992;42:313-317.
9. Soons PA, Vogels BAPM, Roosemalen MCM, Schoemaker HC, Uchida E, Edgar B, et al: Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans. Clin Pharmcol Ther 1991;50:394-403.
10. Van Rooij J, VanDer Merr FJM, Schoemaker HC, Cohen AF: Comparison of the effect of grapefruit juice and cimetidine on pharmacokinetics and anticoagulant effect of a single dose of accenocoumarol. Br J Clin Pharmocol 1993;35:548.
11. Hollander AAMJ, Tooij JV, Lentjes EG, Arbouw F, Van Bree JB, Schoemaker RC, et al: The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clin Pharmacol Ther 1995;57:318-324.
12. Ducharme MP, Provenzano R, Dehoome-Smith M, Edwards DJ: Trough concentrations of cyclosporine following administration with grapefruit juice. Br J Clin Pharmacol 1995;36:457-459.
13. Yee GD, Stanley DL, Pessa L, Dalla Costa T, Beltz SE, Ruiz J, Lowenthal DT: Effect of grapefruit juice on blood cyclosporin concentration. Lancet 1995;345:955-956.
14. Kupferschmidt H, Ha H, Ziegler W, Meier P, Krähenbühl S: Interaction between grapefruit juice and midazolam in humans. Clin Pharmacoi Ther 1995;58:20-28.
15. Bailey DG, Malcolm J, Arnold O, Spence JD: Grapefruit juice and drugs. Clin Pharmacokinet 1994;26:91-98.
16. Proppe DG, Hoch OD, McLean AJ, Visser KE: Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable graft function. Br J Clin Pharmacol 1995;39:337-338.
17. Kessler KM, Lowenthal DT, Warner H, Gibson T, Briggs W: Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med 1974;290:706-709.
18. Kolars J, Stetson P, Rush B, Ruwart MJ, Schmiedlin-Ren P, Duell EA, et al: Cyclosporine metabolism by P450IIIA in rat enterocytes: another determinant of oral bioavailability? Transplantation 1992;53:596-602.
19. Geuntert TW, Holford MJG, Coates PE: Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies. J Pharmacokinet Biopharm 1979;7:315-330.
20. The United States Pharmacopeia, 22nd revision. Rockville, MD: The United States Pharmacopeial Convention, 1994:1617-1619, 1202-1204.
21. Bonora MR, Guentert TW, Upton RA, Riegelman S: Determination of quinidine and metabolites in urine by reverse-phase high-pressure liquid chromatography. Clinical Chimica Acta 1979;91:277-284.
22. Guentert TW, Rakhit A, Upton RA, Riegelman S: An integrated approach to measurements of quinidine and metabolites in biological fluids. J Chromatogr 1980;183:514-518.
23. Chan KKH, Wnuck K: Microcomputer based pharmacokinetic programs for calculating absorption rate. Comput Prog Biomed 1983;16:27-34.
24. Fieldman A, Beebe RD, Chow MSS: The effect of quinidine sulfate on QRS duration and QT and systolic time intervals in man. J Clin Pharmacol 1977;17:134-139.
25. Guentert TW, Holford N, Coates PE, Upton RA, Riegelman S: Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies. J Pharmacokinet Biopharm 1979;7:315-330.
26. Blychert E, Edgar B, Elmfeldt D, Hedner T: A population study of the pharmacokinetics of felodipine. Br J Clin Pharmacol 1991;31:15-24.
27. Regårdh CG, B̈mhielm C, Edgar B, Hoffmann KJ: Pharmacokinetics and biotransformation of 1,4-dihydropyridine calcium antagonists. Prog Drug Metab 1990;12:41-86.
28. Renwick AG, LeVie J, Challenor VF, Waller DG, Gruchy B, George CF: Factors affecting the pharmacokinetics of nifedipine Eur J Clin Pharmacol 1987;32:351-355.
29. Sorkin EM, Clissold SP, Brogden RN: Nifedipine: a review of its pharmacodynamic and pharmacokinetic properties and efficacy in ischemic heart disease, hypertension, and related cardiovascular disorders. Drugs 1985;30:182-274.
30. Fahr A: Cyclosporine clinical pharmacokinetics. Clin Pharmacokinet 1993;24:472-495.
31. Ace LN, Jaffe JM, Kunka RL: Effect of food and an antacid on quinidine bioavailability. Biopharm Drug Dispos 1983;4:183-190.
32. Kahan BD: Cyclosporine. N Engl J Med 1989;321:1725-1738.
33. Hardy BG, Zador ILT, Golden L, Lalka D, Schentag JJ: Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine. Am J Cardiol 1980;48:9-16.
34. Welling PG: Effect of food on drug absorption. Pharmacol Ther 1989;43:425-441.
35. Ochs HR, Greenblatt DJ, Woo E: Clinical pharmacokinetics of quinidine. Clin Pharmacokinet 1980;5:150-168.